- Home
- Pharmaceuticals
- 040-000-294 Oseltamivir Phosphate, CAS 204255-11-8
040-000-294 Oseltamivir Phosphate, CAS 204255-11-8
Synonym | 4R-(acetylamino)-5S-amino-3R-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid, ethyl ester, monophosphate |
Type | Neuaminidase inhibitor |
Keywords | Neuaminidase, influenza |
Related products | Arbidol Hydrochloride, Oseltamivir Acid, Sirolimus |
- Description
Description
Description
Oseltamivir Phosphate Specifications
Product Name | Oseltamivir Phosphate |
CAS Registry Number | 204255-11-8 |
Molecular Formula | C16H28N2O4 • H3PO4 |
Molecular Weight | 410.4 g/mol |
Purity | 98 % |
Appearance | White crystalline powder |
Package | 1kg-25kg |
Shelf life | 2 years |
Functions | inhibitor of neuraminidase, treating influenza |
Oseltamivir Phosphate Description
Oseltamivir is a specific inhibitor of neuraminidase. Its inhibitory effect on neuraminidase can inhibit the mature influenza virus from detaching from host cells, thereby inhibiting the spread of the influenza virus in the human body to play a role in treating influenza. Oseltamivir acid is the active metabolite of oseltamivir.
Tamiflu (oseltamivir phosphate) is an oral antiviral drug approved for the treatment of acute, uncomplicated influenza in patients 2 weeks of age and older whose flu symptoms have not lasted more than two days.
Oseltamivir Phosphate Applications
- Pharmaceutical anti-flu drugs
- Laboratory research
Reference:
- Sidwell, R.W., Huffman, J.H., Barnard, D.L., et al. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. Antiviral Res. 37(2), 107-120 (1998).
- Hayden, F.G., Atmar, R.L., Schilling, M., et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. New England Journal of Medicine 341(18), 1336-1343 (1999).
- Li, W., Escarpe, P.S., Eisenberg, E.J., et al. Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrobial Agents and Chemotherapy 42(3), 647-653 (1998).